Skip to main content
Top
Published in: Heart and Vessels 12/2020

01-12-2020 | Shock | Original Article

Mortality and predictors of survival in patients with recent ventricular septal rupture

Authors: Shigetaka Kageyama, Yuki Nakanishi, Koichiro Murata, Ryuzo Nawada, Tomoya Onodera, Atsushi Sakamoto, Fumio Yamazaki, Yujiro Miura, Yuichiro Maekawa

Published in: Heart and Vessels | Issue 12/2020

Login to get access

Abstract

Ventricular septal rupture (VSR) is a rare but fatal complication after acute myocardial infarction (AMI). However, the mortality in patients with recent VSR and appropriate timing of surgical repair have not been clarified. To examine the background characteristics and mortality of VSR patients as well as the usefulness and appropriate timing of surgery in this patient cohort. Among 3,947 consecutive patients with AMI at our hospital, 39 patients diagnosed with VSR from 2002 to 2020 were included in the analysis. All patients underwent transthoracic echocardiography to confirm VSR on admission. Coronary angiography (CAG) and measurement of pulmonary-systemic flow ratio were performed before emergent surgery. The use of mechanical support devices before or after procedures was considered for all patients who underwent CAG. Basically, we performed emergent or urgent operations to patients who were in a shock state or who needed mechanical support. The final decision of the timing of the operation was made by the cardiac team. Patients’ mean age was 76.3 years, and 33.3% of them were males. Most culprit lesions were located in the left anterior ascending artery (81.3%). The mean pulmonary-systemic flow ratio after VSR onset was 3.07 ± 1.98. On admission, 48.7% of patients were in a shock state. Surgical repair was possible in 28 patients at a median of 1 day after admission, with a mortality rate of 25%. Among all patients, the mortality rate was 43.6%. Survivors were significantly younger (71.3 ± 11.3 vs. 82.7 ± 6.2 years, p < 0.01), had higher mean arterial blood pressure (75.6 ± 14.4 vs. 62.8 ± 16.2 mmHg, p = 0.0496) and lower ejection fraction (44.3 ± 11.7% vs. 54.8 ± 7.9%, p = 0.04), and underwent surgical repair more frequently (95.5% vs. 41.2%, p < 0.01) than the non-survivors. In multivariate analysis, younger age (odds ratio [OR] 1.18 95% confidence interval [CI] 1.01–1.38, p = 0.04) and surgical repair (OR 0.04, 95% CI 0.00–0.73, p = 0.03) were significant predictors of survival. In surgical repair cases, time from admission to operation did not differ significantly between survivors and non-survivors. Surgical repair and younger age are predictors of survival in patients with recent VSR, but the timing of surgery was not.
Literature
1.
go back to reference Jones BM, Kapadia SR, Smedira NG, Robich M, Tuzcu EM, Menon V, Krishnaswamy A (2014) Ventricular septal rupture complicating acute myocardial infarction: a contemporary review. Eur Heart J 35:2060–2068CrossRef Jones BM, Kapadia SR, Smedira NG, Robich M, Tuzcu EM, Menon V, Krishnaswamy A (2014) Ventricular septal rupture complicating acute myocardial infarction: a contemporary review. Eur Heart J 35:2060–2068CrossRef
2.
go back to reference Morillon-Lutun S, Maucort-Boulch D, Mewton N, Farhat F, Bresson D, Girerd N, Desebbe O, Henaine R, Kirkorian G, Bonnefoy-Cudraz E (2013) Therapeutic management changes and mortality rates over 30 years in ventricular septal rupture complicating acute myocardial infarction. Am J Cardiol 112:1273–1278CrossRef Morillon-Lutun S, Maucort-Boulch D, Mewton N, Farhat F, Bresson D, Girerd N, Desebbe O, Henaine R, Kirkorian G, Bonnefoy-Cudraz E (2013) Therapeutic management changes and mortality rates over 30 years in ventricular septal rupture complicating acute myocardial infarction. Am J Cardiol 112:1273–1278CrossRef
3.
go back to reference Crenshaw BS, Granger CB, Birnbaum Y, Pieper KS, Morris DC, Kleiman NS, Vahanian A, Califf RM, Topol EJ (2000) Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (global utilization of streptokinase and TPA for occluded coronary arteries) trial investigators. Circulation 101:27–32CrossRef Crenshaw BS, Granger CB, Birnbaum Y, Pieper KS, Morris DC, Kleiman NS, Vahanian A, Califf RM, Topol EJ (2000) Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (global utilization of streptokinase and TPA for occluded coronary arteries) trial investigators. Circulation 101:27–32CrossRef
4.
go back to reference French JK, Hellkamp AS, Armstrong PW, Cohen E, Kleiman NS, O'Connor CM, Holmes DR, Hochman JS, Granger CB, Mahaffey KW (2010) Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI). Am J Cardiol 105:59–63CrossRef French JK, Hellkamp AS, Armstrong PW, Cohen E, Kleiman NS, O'Connor CM, Holmes DR, Hochman JS, Granger CB, Mahaffey KW (2010) Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI). Am J Cardiol 105:59–63CrossRef
5.
go back to reference López-Sendón J, Gurfinkel EP, Lopez de Sa E, Agnelli G, Gore JM, Steg PG, Eagle KA, Cantador JR, Fitzgerald G, Granger CB, Global Registry of Acute Coronary Events (GRACE) Investigators (2010) Factors related to heart rupture in acute coronary syndromes in the global registry of acute coronary events. Eur Heart J 31:1449–1456CrossRef López-Sendón J, Gurfinkel EP, Lopez de Sa E, Agnelli G, Gore JM, Steg PG, Eagle KA, Cantador JR, Fitzgerald G, Granger CB, Global Registry of Acute Coronary Events (GRACE) Investigators (2010) Factors related to heart rupture in acute coronary syndromes in the global registry of acute coronary events. Eur Heart J 31:1449–1456CrossRef
6.
go back to reference Moreyra AE, Huang MS, Wilson AC, Deng Y, Cosgrove NM, Kostis JB, MIDAS Study Group (MIDAS 13) (2010) Trends in incidence and mortality rates of ventricular septal rupture during acute myocardial infarction. Am J Cardiol 106:1095–1100CrossRef Moreyra AE, Huang MS, Wilson AC, Deng Y, Cosgrove NM, Kostis JB, MIDAS Study Group (MIDAS 13) (2010) Trends in incidence and mortality rates of ventricular septal rupture during acute myocardial infarction. Am J Cardiol 106:1095–1100CrossRef
7.
go back to reference Hochman JS, Sleeper LA, Godfrey E, McKinlay SM, Sanborn T, Col J, LeJemtel T (1999) Should we emergently revascularize occluded coronaries for cardiogenic shock: an international randomized trial of emergency PTCA/CABGtrial design. The SHOCK trial study group. Am Heart J 137:313–321CrossRef Hochman JS, Sleeper LA, Godfrey E, McKinlay SM, Sanborn T, Col J, LeJemtel T (1999) Should we emergently revascularize occluded coronaries for cardiogenic shock: an international randomized trial of emergency PTCA/CABGtrial design. The SHOCK trial study group. Am Heart J 137:313–321CrossRef
8.
go back to reference O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61:485–510CrossRef O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61:485–510CrossRef
9.
go back to reference Menon V, Webb JG, Hillis LD, Sleeper LA, Abboud R, Dzavik V, Slater JN, Forman R, Monrad ES, Talley JD, Hochman JS (2000) Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries in cardiogenic shock? J Am Coll Cardiol 36:1110–1116CrossRef Menon V, Webb JG, Hillis LD, Sleeper LA, Abboud R, Dzavik V, Slater JN, Forman R, Monrad ES, Talley JD, Hochman JS (2000) Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries in cardiogenic shock? J Am Coll Cardiol 36:1110–1116CrossRef
10.
go back to reference Giuliani ER, Danielson GK, Pluth JR, Odyniec NA, Wallace RB (1974) Postinfarction ventricular septal rupture: surgical considerations and results. Circulation 49:455–459CrossRef Giuliani ER, Danielson GK, Pluth JR, Odyniec NA, Wallace RB (1974) Postinfarction ventricular septal rupture: surgical considerations and results. Circulation 49:455–459CrossRef
11.
go back to reference Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, Schönberger JP, Buller N, Bonser R, Disco C, Backx B, Hugenholtz PG, Firth BG, Unger F (2005) Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the arterial revascularization therapies study (ARTS) randomized trial. J Am Coll Cardiol 46:575–581CrossRef Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, Schönberger JP, Buller N, Bonser R, Disco C, Backx B, Hugenholtz PG, Firth BG, Unger F (2005) Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the arterial revascularization therapies study (ARTS) randomized trial. J Am Coll Cardiol 46:575–581CrossRef
12.
go back to reference Takii T, Yasuda S, Takahashi J, Ito K, Shiba N, Shirato K, Shimokawa H, MIYAGI-AMI Study Investigators (2010) Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI Registry Study. Circ J 74:93–100CrossRef Takii T, Yasuda S, Takahashi J, Ito K, Shiba N, Shirato K, Shimokawa H, MIYAGI-AMI Study Investigators (2010) Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI Registry Study. Circ J 74:93–100CrossRef
13.
go back to reference Arnaoutakis GJ, Zhao Y, George TJ, Sciortino CM, McCarthy PM, Conte JV (2012) Surgical repair of ventricular septal defect after myocardial infarction: outcomes from the Society of Thoracic Surgeons National Database. Ann Thorac Surg 94:436–443CrossRef Arnaoutakis GJ, Zhao Y, George TJ, Sciortino CM, McCarthy PM, Conte JV (2012) Surgical repair of ventricular septal defect after myocardial infarction: outcomes from the Society of Thoracic Surgeons National Database. Ann Thorac Surg 94:436–443CrossRef
14.
go back to reference Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WMM, Vlachopoulos C, Wood DA, Zamorano JL, Cooney MT, ESC Scientific Document Group (2016) 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J 37:2999–3058CrossRef Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WMM, Vlachopoulos C, Wood DA, Zamorano JL, Cooney MT, ESC Scientific Document Group (2016) 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J 37:2999–3058CrossRef
15.
go back to reference Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J (2019) 2018 AHA/ACC/AACVPR/AAPA/ABC/ ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 73:e285–e350CrossRef Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J (2019) 2018 AHA/ACC/AACVPR/AAPA/ABC/ ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 73:e285–e350CrossRef
16.
go back to reference Ray KK, Cannon CP, McCabe CH, Cairns R, Tonkin AM, Sacks FM, Jackson G, Braunwald E, PROVE IT-TIMI 22 Investigators (2005) Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 46:1405–1410CrossRef Ray KK, Cannon CP, McCabe CH, Cairns R, Tonkin AM, Sacks FM, Jackson G, Braunwald E, PROVE IT-TIMI 22 Investigators (2005) Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 46:1405–1410CrossRef
17.
go back to reference Marenzi G, Cosentino N, Cortinovis S, Milazzo V, Rubino M, Cabiati A, De Metrio M, Moltrasio M, Lauri G, Campodonico J, Pontone G, Andreini D, Bonomi A, Veglia F, Bartorelli A (2015) Myocardial infarct size in patients on long-term statin therapy undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol 116:1791–1797CrossRef Marenzi G, Cosentino N, Cortinovis S, Milazzo V, Rubino M, Cabiati A, De Metrio M, Moltrasio M, Lauri G, Campodonico J, Pontone G, Andreini D, Bonomi A, Veglia F, Bartorelli A (2015) Myocardial infarct size in patients on long-term statin therapy undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol 116:1791–1797CrossRef
18.
go back to reference Bao N, Ushikoshi H, Kobayashi H, Yasuda S, Kawamura I, Iwasa M, Yamaki T, Sumi S, Nagashima K, Aoyama T, Kawasaki M, Nishigaki K, Takemura G, Minatoguchi S (2009) Simvastatin reduces myocardial infarct size via increased nitric oxide production in normocholesterolemic rabbits. J Cardiol 53:102–107CrossRef Bao N, Ushikoshi H, Kobayashi H, Yasuda S, Kawamura I, Iwasa M, Yamaki T, Sumi S, Nagashima K, Aoyama T, Kawasaki M, Nishigaki K, Takemura G, Minatoguchi S (2009) Simvastatin reduces myocardial infarct size via increased nitric oxide production in normocholesterolemic rabbits. J Cardiol 53:102–107CrossRef
19.
go back to reference Estrada-Quintero T, Uretsky BF, Murali S, Hardesty RL (1992) Prolonged intraaortic balloon support for septal rupture after myocardial infarction. Ann Thorac Surg 53:335–337CrossRef Estrada-Quintero T, Uretsky BF, Murali S, Hardesty RL (1992) Prolonged intraaortic balloon support for septal rupture after myocardial infarction. Ann Thorac Surg 53:335–337CrossRef
20.
go back to reference Koeda Y, Itoh T, Ishikawa Y, Morino Y, Mizutani T, Ako J, Nakano M, Yoshioka K, Ikari Y, Inami S, Sakuma M, Taguchi I, Ishikawa T, Sugimura H, Sugi K, Matsumoto K, Mitarai T, Kunishima T, Akashi YJ, Nomura T, Fukushi K, Yoshino H, Cardiovascular Research Consortium-8 Universities (CIRC-8U) (2020) A multicenter study on the clinical characteristics and risk factors of in-hospital mortality in patients with mechanical complications following acute myocardial infarction. Heart Vessels. https://doi.org/10.1007/s00380-020-01586-0CrossRef Koeda Y, Itoh T, Ishikawa Y, Morino Y, Mizutani T, Ako J, Nakano M, Yoshioka K, Ikari Y, Inami S, Sakuma M, Taguchi I, Ishikawa T, Sugimura H, Sugi K, Matsumoto K, Mitarai T, Kunishima T, Akashi YJ, Nomura T, Fukushi K, Yoshino H, Cardiovascular Research Consortium-8 Universities (CIRC-8U) (2020) A multicenter study on the clinical characteristics and risk factors of in-hospital mortality in patients with mechanical complications following acute myocardial infarction. Heart Vessels. https://​doi.​org/​10.​1007/​s00380-020-01586-0CrossRef
Metadata
Title
Mortality and predictors of survival in patients with recent ventricular septal rupture
Authors
Shigetaka Kageyama
Yuki Nakanishi
Koichiro Murata
Ryuzo Nawada
Tomoya Onodera
Atsushi Sakamoto
Fumio Yamazaki
Yujiro Miura
Yuichiro Maekawa
Publication date
01-12-2020
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 12/2020
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-020-01652-7

Other articles of this Issue 12/2020

Heart and Vessels 12/2020 Go to the issue